Literature DB >> 2914956

The molecular defect in a COOH-terminal-modified and shortened mutant of human serum albumin.

L Minchiotti1, M Galliano, P Iadarola, M L Meloni, G Ferri, F Porta, A A Castellani.   

Abstract

Albumin Venezia is a fast migrating genetic variant of human serum albumin which, in heterozygous subjects, represents about 30% of the circulating protein. The molecular defect in this variant was studied in a subject possessing an atypical level of the mutant (80% of the total protein) and in other members of his family. Albumins, isolated from the sera of the propositus and his heterozygous relatives, were treated with CNBr and the resulting fragments analyzed by isoelectric focusing. The peptides were then isolated in a homogeneous form by reverse-phase high performance liquid chromatography and submitted to sequence analysis. The results show that albumin Venezia possesses a shortened polypeptide chain, 578 residues instead of 585, completely variant from residue 572 to the COOH-terminal end: sequence: (see text). This extensive modification may be accounted for by the deletion of exon 14 and translation to the first terminator codon of exon 15, which normally does not code for protein. The absence of a basic COOH-terminal dipeptide in the mature molecule can be explained by the probable action of serum carboxypeptidase N. Additional support for such action comes from examination of the remaining 20% of the total albumin of the propositus, which is found to contain an extra Arg at its COOH terminus, probably due to partial digestion by carboxypeptidase N. The low serum level of the variant in heterozygous subjects suggests that the COOH-terminal end of the molecule is critical for albumin stability.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2914956

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Point substitutions in albumin genetic variants from Asia.

Authors:  K Arai; J Madison; A Shimizu; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

2.  Identification of a 130-kDa albumin in tuatara (Sphenodon) and detection of a novel albumin polymorphism.

Authors:  M A Brown; A Carne; C H Daugherty; G K Chambers
Journal:  Biochem Genet       Date:  1995-06       Impact factor: 1.890

Review 3.  Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding.

Authors:  F Hervé; S Urien; E Albengres; J C Duché; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

4.  Mutations in genetic variants of human serum albumin found in Italy.

Authors:  M Galliano; L Minchiotti; F Porta; A Rossi; G Ferri; J Madison; S Watkins; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

5.  A donor splice mutation and a single-base deletion produce two carboxyl-terminal variants of human serum albumin.

Authors:  S Watkins; J Madison; E Davis; Y Sakamoto; M Galliano; L Minchiotti; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

6.  High-affinity binding of laurate to naturally occurring mutants of human serum albumin and proalbumin.

Authors:  U Kragh-Hansen; A O Pedersen; M Galliano; L Minchiotti; S O Brennan; A L Tárnoky; M H Franco; F M Salzano
Journal:  Biochem J       Date:  1996-12-15       Impact factor: 3.857

7.  Hypermutability of CpG dinucleotides in the propeptide-encoding sequence of the human albumin gene.

Authors:  S O Brennan; K Arai; J Madison; C B Laurell; M Galliano; S Watkins; R Peach; T Myles; P George; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

8.  Post-translational arginylation of ornithine decarboxylase from rat hepatocytes.

Authors:  J Kopitz; B Rist; P Bohley
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

9.  Genetic variants of human serum albumin in Italy: point mutants and a carboxyl-terminal variant.

Authors:  J Madison; M Galliano; S Watkins; L Minchiotti; F Porta; A Rossi; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

10.  An intact C-terminal end of albumin is required for its long half-life in humans.

Authors:  Jeannette Nilsen; Esben Trabjerg; Algirdas Grevys; Claudia Azevedo; Stephen O Brennan; Maria Stensland; John Wilson; Kine Marita Knudsen Sand; Malin Bern; Bjørn Dalhus; Derry C Roopenian; Inger Sandlie; Kasper Dyrberg Rand; Jan Terje Andersen
Journal:  Commun Biol       Date:  2020-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.